 |
인쇄하기
취소
|
Nexavar improves survival in liver cancer
Nexavar (sorafenib) tablets significantly improved overall survival by 47.3 percent in patients in the Asia-Pacific region with advanced hepatocellular carcinoma (HCC), according to Bayer HealthCare.
In a local symposium organized by the Korean Cancer Association, Dr. Tim F. Greten, Hannover School of Medicine in Hamburg, said that Nexavar demonstrated a clear survival benefit in Asia-Pacifi...
In a local symposium organized by the Korean Cancer Association, Dr. Tim F. Greten, Hannover School of Medicine in Hamburg, said that Nexavar demonstrated a clear survival benefit in Asia-Pacifi...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.